Posted on 1/17/18
Kairoi Health Partners with athenahealth
Kairoi Healthcare Strategies, Inc. (Kairoi Health) today announced the launch of KairoiScheduler™, its novel solution for clinic schedule optimization, on athenahealth's marketplace, More Disruption Please. KairoiScheduler . . .
Posted on 1/17/18
Hologic Prices Offering of $1 Billion of Senior Notes
Hologic, Inc. (Nasdaq: HOLX) announced today that it has priced and allocated its previously announced private offering of $1 billion in aggregate principal amount of senior . . .
Posted on 1/17/18
Cerveau Technologies Signs Research Agreement with University of Pittsburgh
BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced an agreement with the University of Pittsburgh to support multiple projects over the next several years. These research projects are . . .
Posted on 1/16/18
Foundation Medicine and Pfizer Announce Broad Partnership
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the company has entered into a broad partnership with Pfizer Inc. (NYSE: PFE). The partnership focuses on . . .
Posted on 1/16/18
5 Biotech Stocks That Could Be Bought Out in 2018
Biotechnology merger and acquisition activity could get a booster shot now that U.S. tax reform is cutting corporate tax rates and allowing companies to repatriate cash . . .
Posted on 1/16/18
Will 2018 Be Biogen Inc.'s Best Year Yet?
Some questions are flat out hard to answer. Others are easy as can be. I'd put the question of whether 2018 will be Biogen's (NASDAQ:BIIB) best . . .
Posted on 1/12/18
Peak Physical Therapy & Sports Performance Promotes Ryan Burke To Assistant Clinic Manager of Hanover Location
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique
Posted on 1/11/18
NANOBIOTIX Partners with the Providence Cancer Institute
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--NANOBIOTIX(Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced it will . . .
Posted on 1/11/18
Here's What Warren Buffett Just Said About Bitcoin
Warren Buffett, the billionaire investor and CEO of Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B), expressed his opinions on bitcoin and other cryptocurrencies in a CNBC interview, and it's fair . . .
Posted on 1/10/18
Adimab Announces Antibody Discovery Collaboration with Boehringer Ingelheim
LEBANON, N.H.--(BUSINESS WIRE)--Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced a multi-target partnership with Boehringer . . .
Posted on 1/10/18
Quad Technologies Partners With Sartorius Stedim Biotech
WOBURN, Mass.--(BUSINESS WIRE)--Quad Technologies, a visionary innovator in cell and gene therapy bioprocessing, today announced a collaboration with Sartorius Stedim Biotech, a leading provider of cutting-edge . . .
Posted on 1/10/18
CVS Merger Is A Positive Sign
After poor performance over the past years, CVS Health Corporation (CVS) seems ready for a breakthrough. The company has taken the right steps to improve its . . .
Posted on 1/10/18
10 Things to Expect From Vertex Pharmaceuticals in 2018
No big biotech stock performed better than Vertex Pharmaceuticals (NASDAQ:VRTX) did in 2017, with a market cap that more than doubled. CEO Jeff Leiden was certainly . . .
Posted on 1/10/18
Voluntis and WellDoc Announce Partnership
CAMBRIDGE, Mass. and COLUMBIA, Md., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Voluntis and WellDoc®, two of the industry’s leading digital therapeutics companies, announced today a commercial . . .
Posted on 1/9/18
MEDITECH Announces Collaboration with Arcadia Healthcare Solutions
MEDITECH, a leading Enterprise Health Record (EHR) vendor, is pleased to announce a collaboration with Arcadia Healthcare Solutions to integrate aggregated data into MEDITECH's Web EHR . . .
Posted on 1/9/18
bluebird bio Closes Over-Allotment Option in Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for . . .
Posted on 1/8/18
Veritas Genetics Launches Collaboration with Mayo Clinic
Veritas Genetics, The Genome Company, and Mayo Clinic are entering into an agreement to make whole genome sequencing broadly available to healthy individuals.As part of this . . .
Posted on 1/8/18
Syros Announces 2018 Strategic Priorities
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes, today outlined its strategic plan and . . .
Posted on 1/8/18
3 Big Biotech Stocks to Buy in January
Biotech was hot yet again in 2017. The SPDR S&P Biotech ETF soared more than 43% last year. Many biotech stocks performed even better than that.For . . .
Posted on 1/8/18
Idera Pharmaceuticals Provides 2018 Update and Outlook
EXTON, Pa. and CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization . . .
Posted on 1/8/18
RXi Pharmaceuticals Announces Reverse Stock Split
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage company developing a new class of RNAi-based therapeutics, today announced a reverse stock split of its shares of common . . .
Posted on 1/8/18
Potenza Therapeutics Unveils Pipeline of Immuno-Oncology Programs
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Potenza Therapeutics today provided insights into its portfolio of immuno-oncology therapies that turn on or off the signaling mechanisms that control a patients‘ own . . .
Posted on 1/8/18
Miami VA Healthcare System Adds LiveData PeriOp Planner to Streamline Patient Access to Surgical Care
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LiveData, Inc.today announced that the Miami Department of Veterans Affairs healthcare facility has addedLiveData PeriOp Planner™ to the medical center’s LiveData PeriOp Manager™ workflow . . .
Posted on 1/8/18
Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with BeiGene
SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Harbour BioMed announced today that it has licensed its patented H2L2 transgenic mouse platform for generating fully human . . .
Posted on 1/8/18
Alnylam and Sanofi Enter into Strategic Restructuring of RNAi Therapeutics Rare Disease Alliance
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, andSanofiannounced today a strategic restructuring of their RNAi therapeutics alliance to streamline . . .

